These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
219 related articles for article (PubMed ID: 36214209)
21. Pharmaceutical, biomedical and ophthalmic applications of biodegradable polymers (BDPs): literature and patent review. Osi B; Khoder M; Al-Kinani AA; Alany RG Pharm Dev Technol; 2022 Mar; 27(3):341-356. PubMed ID: 35297285 [TBL] [Abstract][Full Text] [Related]
22. The potential of polyphosphazenes for delivery of vaccine antigens and immunotherapeutic agents. Eng NF; Garlapati S; Gerdts V; Potter A; Babiuk LA; Mutwiri GK Curr Drug Deliv; 2010 Jan; 7(1):13-20. PubMed ID: 19863483 [TBL] [Abstract][Full Text] [Related]
23. Advances in biodegradable and injectable hydrogels for biomedical applications. Li Y; Yang HY; Lee DS J Control Release; 2021 Feb; 330():151-160. PubMed ID: 33309972 [TBL] [Abstract][Full Text] [Related]
24. Biodegradable particles as vaccine antigen delivery systems for stimulating cellular immune responses. Joshi VB; Geary SM; Salem AK Hum Vaccin Immunother; 2013 Dec; 9(12):2584-90. PubMed ID: 23978910 [TBL] [Abstract][Full Text] [Related]
25. Mucosal delivery of vaccines: role of mucoadhesive/biodegradable polymers. Garg NK; Mangal S; Khambete H; Tyagi RK Recent Pat Drug Deliv Formul; 2010 Jun; 4(2):114-28. PubMed ID: 20380624 [TBL] [Abstract][Full Text] [Related]
33. [Development of vaccine adjuvants using polymeric nanoparticles and their potential applications for anti-HIV vaccine]. Akagi T; Baba M; Akashi M Yakugaku Zasshi; 2007 Feb; 127(2):307-17. PubMed ID: 17268151 [TBL] [Abstract][Full Text] [Related]
34. Biodegradable polymers for targeted delivery of anti-cancer drugs. Doppalapudi S; Jain A; Domb AJ; Khan W Expert Opin Drug Deliv; 2016 Jun; 13(6):891-909. PubMed ID: 26983898 [TBL] [Abstract][Full Text] [Related]
35. Quaternized Chitosan Nanoparticles in Vaccine Applications. Yu S; Hao S; Sun B; Zhao D; Yan X; Jin Z; Zhao K Curr Med Chem; 2020; 27(30):4932-4944. PubMed ID: 30827229 [TBL] [Abstract][Full Text] [Related]
36. Micro- and nanoparticle-based vaccines for hepatitis B. Bharali DJ; Mousa SA; Thanavala Y Adv Exp Med Biol; 2007; 601():415-21. PubMed ID: 17713030 [TBL] [Abstract][Full Text] [Related]
37. Recent advances on biocompatible and biodegradable nanoparticles as gene carriers. Mokhtarzadeh A; Alibakhshi A; Yaghoobi H; Hashemi M; Hejazi M; Ramezani M Expert Opin Biol Ther; 2016 Jun; 16(6):771-85. PubMed ID: 26998622 [TBL] [Abstract][Full Text] [Related]
38. Hydrogel swelling as a trigger to release biodegradable polymer microneedles in skin. Kim M; Jung B; Park JH Biomaterials; 2012 Jan; 33(2):668-78. PubMed ID: 22000788 [TBL] [Abstract][Full Text] [Related]
39. Application of nanohydrogels in drug delivery systems: recent patents review. Dalwadi C; Patel G Recent Pat Nanotechnol; 2015; 9(1):17-25. PubMed ID: 25553508 [TBL] [Abstract][Full Text] [Related]
40. Modulation of injectable hydrogel properties for slow co-delivery of influenza subunit vaccine components enhance the potency of humoral immunity. Saouaf OM; Roth GA; Ou BS; Smith AAA; Yu AC; Gale EC; Grosskopf AK; Picece VCTM; Appel EA J Biomed Mater Res A; 2021 Nov; 109(11):2173-2186. PubMed ID: 33955657 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]